Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Clarivate
CLVT
$1.24B
| $2.54M | ﹤0.01% |
270,651
-12,931
| -5% | -$133K |
|
1977
Avnet
AVT
$7.29B
| $2.53M | ﹤0.01% |
56,040
+5,622
| +11% | +$250K |
|
1978
Lumentum
LITE
$60.7B
| $2.53M | ﹤0.01% |
46,838
+23,664
| +102% | +$1.32M |
|
1979
Revolve Group
RVLV
$1.86B
| $2.53M | ﹤0.01% |
96,138
+85,172
| +777% | +$2.2M |
|
1980
PUT
Robinhood
HOOD
$81.2B
| $2.52M | ﹤0.01% |
260,000
-668,600
| -72% | -$6.38M |
|
1981
SkinHealth Systems
SKIN
$90.6M
| $2.52M | ﹤0.01% |
199,733
+50,064
| +33% | +$579K |
|
1982
CALL
Danaher
DHR
$139B
| $2.52M | ﹤0.01% |
11,280
+3,158
| +39% | +$718K |
|
|
GMFI
1983
DELISTED
Aetherium Acquisition Corp
GMFI
| $2.52M | ﹤0.01% |
240,015
| – | – |
|
1984
CALL
Bilibili
BILI
$8.05B
| $2.51M | ﹤0.01% |
+106,900
| New | +$2.54M |
|
1985
Cathay General Bancorp
CATY
$4.27B
| $2.51M | ﹤0.01% |
72,750
+34,959
| +93% | +$1.44M |
|
1986
Upbound Group
UPBD
$1.18B
| $2.51M | ﹤0.01% |
102,449
+1,985
| +2% | +$51.1K |
|
1987
WaFd
WAFD
$2.76B
| $2.51M | ﹤0.01% |
83,190
+29,499
| +55% | +$998K |
|
1988
Adient
ADNT
$1.65B
| $2.5M | ﹤0.01% |
61,107
+12,749
| +26% | +$532K |
|
|
CPE
1989
DELISTED
Callon Petroleum Company
CPE
| $2.5M | ﹤0.01% |
74,808
+26,892
| +56% | +$1.01M |
|
|
ALE
1990
DELISTED
Allete
ALE
| $2.5M | ﹤0.01% |
38,832
+19,322
| +99% | +$1.21M |
|
|
BECN
1991
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $2.5M | ﹤0.01% |
42,458
+15,217
| +56% | +$891K |
|
1992
Veeco
VECO
$3.11B
| $2.49M | ﹤0.01% |
117,812
-6,621
| -5% | -$136K |
|
1993
BCE
BCE
$20.3B
| $2.49M | ﹤0.01% |
55,577
-29,867
| -35% | -$1.35M |
|
1994
Community Bank
CBU
$3.5B
| $2.49M | ﹤0.01% |
47,395
+12,384
| +35% | +$725K |
|
1995
AngloGold Ashanti
AU
$41.3B
| $2.49M | ﹤0.01% |
102,833
-250,977
| -71% | -$5.08M |
|
1996
Neogen
NEOG
$2.59B
| $2.48M | ﹤0.01% |
134,162
-678,732
| -83% | -$12.8M |
|
1997
Rithm Capital
RITM
$5.62B
| $2.47M | ﹤0.01% |
309,169
-24,375
| -7% | -$214K |
|
1998
Allogene Therapeutics
ALLO
$635M
| $2.47M | ﹤0.01% |
500,651
+77,598
| +18% | +$498K |
|
1999
Seacoast Banking Corp of Florida
SBCF
$3.38B
| $2.47M | ﹤0.01% |
104,304
+56,762
| +119% | +$1.69M |
|
2000
WesBanco
WSBC
$4.01B
| $2.47M | ﹤0.01% |
80,443
+20,078
| +33% | +$710K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.